1. Evaluate patients for common clinical features of substance use disorders and justify the role of the pharmacist in managing these symptoms.

2. Assess pharmacotherapy prevention and treatments for patients with opioid use disorder.

3. Distinguish the role and place in therapy of naltrexone, topiramate, acamprosate, disulfiram, and gabapentin in the chronic management of alcohol use disorder.

4. Evaluate emerging strategies for the treatment of stimulant use disorder and stimulant withdrawal.

1. Distinguish between different depressive disorders according to their proposed pathophysiology and clinical presentation.

2. Develop a pharmacotherapy plan for a patient with major depressive disorder (MDD) according to treatment guidelines and patient-specific characteristics.

3. Develop a pharmacotherapy plan for a patient with postpartum depression (PPD) according to treatment guidelines and patient-specific characteristics.

4. Evaluate the appropriateness of pharmacotherapy for a patient who is pregnant or breastfeeding.

5. Distinguish between serotonergic antidepressant medications and novel treatments for depressive disorders.

6. Evaluate a patient for suicidality and the appropriateness of pharmacologic and nonpharmacologic treatments.

1. Classify the clinical symptoms of schizophrenia.

2. Analyze the differences between the classes of antipsychotic medications.

3. Distinguish between the characteristics of the long-acting injectable antipsychotic medications.

4. Design a treatment plan for the use of clozapine.

5. Develop a monitoring plan for a patient with schizophrenia being treated with antipsychotic medication. 

1. Assess patients across the age spectrum for clinical features of autism spectrum disorder (ASD).

2. Develop comprehensive patient-specific strategies for managing functionally impairing characteristics common in the presentation of ASD.

3. Design targeted supportive pharmacotherapy for a patient with functionally impairing neuropsychiatric symptoms related to ASD.

4. Evaluate the appropriateness of therapy for a patient receiving medications for ASD-related symptoms.

1. Distinguish the multifactorial contributions to the pathophysiology of overweight and obesity development in pediatric patients.

2. Evaluate nonpharmacologic interventions for pediatric patients with overweight and obesity.

3. Assess and select pharmacotherapeutic options for a pediatric patient with overweight or obesity on the basis of patient-specific factors.

1. Distinguish pediatric-specific thrombotic risk factors and characterize difficulties unique to assessing thrombosis and hemostasis in the pediatric population.

2. Analyze and apply appropriate intravenous and subcutaneous pharmacotherapeutic options for a pediatric patient diagnosed with and/or at high risk of thrombosis.

3. Analyze and apply appropriate oral pharmacotherapeutic options for a pediatric patient diagnosed with and/or at high risk of thrombosis.

4. Analyze and apply appropriate antiplatelet pharmacotherapeutic options and monitoring for a pediatric patient diagnosed with and/or at high risk of thrombosis.

5. Evaluate the appropriate duration of anticoagulation therapy for pediatric thrombosis and determine the necessity for chronic thromboprophylaxis.

1. Classify vaccines into active and passive immunity, and distinguish how each type of immunity contributes to the effectiveness of vaccines in safeguarding pediatric patients against specific diseases.

2. Assess and select vaccines for a pediatric patient or an adult caregiver on the basis of patient-specific factors.

3. Evaluate evidence-based information to counter myths and misinformation, and communicate effectively with hesitant parents.

4. Evaluate techniques to minimize discomfort and anxiety, and analyze strategies for effectively managing adverse reactions.

1. Differentiate among common pediatric respiratory illnesses such as cold, cough, influenza and COVID-19.

2. Apply knowledge of evidence-based treatment guidelines for managing pediatric cough, cold, influenza and COVID-19.

3. Identify high-risk symptoms of influenza in infants and determine when antiviral treatment is indicated.

4. Evaluate the safety and efficacy of OTC medications for treating cough in children.